| Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). | | Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K. and Yamamoto, M. | Mol. Cell. Biol.   24, 36-45  (2004 ) | | |
| | | |
| Characterization of the pufferfish Otx2 cis-regulators reveals evolutionarily conserved genetic mechanisms for vertebrate head specification. | | Kimura-Yoshida C, Kitajima K, Oda-Ishii I, Tian E, Suzuki M, Yamamoto M, Suzuki T, Kobayashi M, Aizawa S, Matsuo I. | Development   131, 57-71  (2004) | | |
| | | |
| A constitutively active arylhydrocarbon receptor induces growth inhibition of Jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest. | | Ito T, Tsukumo S-i, Suzuki N, Motohashi H, Yamamoto M, Fujii-Kuriyama Y, Mimura J, Tien-Min Lin, Richard E.P, Tohyama C, and Nohara K | J. Biol. Chem.   279, 25204-25210  (2004) | | |
| | | |
| Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. | | Goldring C.E.P., Kitteringham N.R, Elsby R, Randle L.E, Clement Y.N, Williams D.P, McMahon M, Hayes J.D, Itoh K, Yamamoto M, Park B.K. | Hepatology   39, 1267-1276  (2004) | | |
| | | |
| Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox sensitive Neh2 degron and the redox-insensitive Neh6 degron. | | McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. and Hayes, J.D. | J. Biol. Chem.   279, 31556-31567  (2004) | | |
| | | |
| Identification of polymorphisms in the promoter region of the human NRF2 gene. | | Yamamoto T, Yoh K, Kobayashi A, Ishii Y, Kure S, Koyama A, Sakamoto T, Sekizawa K, Motohashi H, Yamamoto M. | Biochem. Biophys. Res. Commun.   321, 72-79  (2004) | | |
| | | |
| Multiple, Distant Gata2 Enhancers Specify Temporally and Tissue-Specific Patterning in the Developing Urogenital System. | | Khandekar, M., Suzuki, N., Lewton, J., Yamamoto M, and Engel, J.D. | Mol. Cell. Biol.   24, 10263-10276  (2004) | | |
| | | |
| Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. | | Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S. | J. Clin. Invest.   114, 1248-1259  (2004) | | |
| | | |
| Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease. | | Nakano Y, Imagawa S, Matsumoto K, Stockmann C, Obara N, Suzuki N, Doi T, Kodama T, Takahashi S, Nagasawa T, Yamamoto M. | Blood   104, 4300-4307  (2004) | | |
| | | |
| Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. | | McWalter GK, Higgins LG, McLellan LI, Henderson CJ, Song L, Thornalley PJ, Itoh K, Yamamoto M, Hayes JD. | J. Nutr.   134, 3499S-3506S  (2004) | (Suppl) | |
| | | |
| Leukemogenesis caused by incapacitated GATA-1 function. | | Shimizu, R., Kuroha, T., Ohneda, O., Pan, X., Ohneda, K., Takahahshi, S., Philipsen, S., Yamamoto, M. | Mol. Cell. Biol.   24, 10814-10825  (2004) | | |
| | | |
|